Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Prognostic Studies

Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome

Abstract

Hepatocyte growth factor (HGF) is a potent angiogenic factor. The aim of our study was to evaluate plasma HGF levels and their prognostic significance in patients with newly diagnosed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). The sandwich enzyme immunoassay technique was used to quantify HGF in stored samples obtained before treatment from patients with AML (59 patients) and MDS (42 patients) treated at The University of Texas MD Anderson Cancer Center. HGF levels were significantly higher in patients with AML or MDS than in healthy individuals (P < 0.0001). Higher HGF levels in both AML and MDS correlated significantly with white blood cell (P = 0.000001 for both groups) and monocyte counts (P = 0.0004 and 0.003, respectively), and with poor performance status (P = 0.03 and 0.001, respectively). Using Cox proportional hazard model and HGF levels as a continuous variable, plasma levels of HGF correlated with shorter survival of AML (P = 0.001), but not MDS (P = 0.34) patients. No significant correlation was observed between HGF levels and complete remission rate or duration. In the multivariate analysis HGF retained its significance as prognostic factor in AML (P = 0.02), along with age (P = 0.0005).

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

References

  1. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F . Bone marrow angiogenesis and progression in multiple myeloma Br J Haematol 1994 87: 503–508

    Article  CAS  PubMed  Google Scholar 

  2. Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R, Albini A, Bussolino F, Dammacco F . Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma Blood 1999 93: 3064–3073

    CAS  PubMed  Google Scholar 

  3. Vacca A, Di Loreto M, Ribatti D, Di Stefano R, Gadaleta-Caldarola G, Iodice G, Caloro D, Dammacco F . Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44 Am J Hematol 1995 50: 9–14

    Article  CAS  PubMed  Google Scholar 

  4. Ribatti D, Vacca A, Nico B, Quondamatteo F, Ria R, Minischetti M, Marzullo A, Herken R, Roncali L, Dammacco F . Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma Br J Cancer 1999 79: 451–455

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Ribatti D, Vacca A, Nico B, Fanelli M, Roncali L, Dammacco F . Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas. An immunohistochemical and ultrastructural study Eur J Haematol 1996 56: 45–53

    Article  CAS  PubMed  Google Scholar 

  6. Ribatti D, Nico B, Vacca A, Marzullo A, Calvi N, Roncali L, Dammacco F . Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas? Br J Cancer 1998 77: 1900–1906

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Vacca A, Ribatti D, Ruco L, Giacchetta F, Nico B, Quondamatteo F, Ria, R Iurlaro M, Dammacco F . Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas Br J Cancer 1999 79: 965–970

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J . Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia Am J Pathol 1997 150: 815–821

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Pruneri G, Bertolini F, Soligo D, Carboni N, Cortelezzi A, Ferrucci PF, Buffa R, Lambertenghi-Deliiers G, Pezzella F . Angiogenesis in myelodysplastic syndromes Br J Cancer 1999 81: 1398–1401

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lundberg LG, Lerner R, Sundelin P, Rogers R, Folkman J, Palmblad J . Bone marrow in polycythemia vera, chronic myelocytic leukemia, and myelofibrosis has an increased vascularity Am J Pathol 2000 157: 15–19

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Hussong JW, Rodgers GM, Shami PJ . Evidence of increased angiogenesis in patients with acute myeloid leukemia Blood 2000 95: 309–313

    CAS  PubMed  Google Scholar 

  12. Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Thomas D, Koller C, Estrov Z, O'Brien S, Keating M, Frieriech E, Albitar M . Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes Blood 2000 96: 2240–2245

    CAS  PubMed  Google Scholar 

  13. Jones A, Harris AL . New developments in angiogenesis: a major mechanism for tumor growth and target for therapy Cancer J Sci Am 1998 4: 209–217

    CAS  PubMed  Google Scholar 

  14. Gruber G, Schwarzmeier JD, Shehata M, Hilgarth M, Berger R . Basic fibroblast growth factor is expressed by CD19/CD11c-positive cells in hairy cell leukemia Blood 1999 94: 1077–1185

    CAS  PubMed  Google Scholar 

  15. Fiedler W, Graeven U, Ergun S, Verago S, Kilic N, Stockschlader M, Hossfeld DK . Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia Blood 1997 89: 1870–1875

    CAS  PubMed  Google Scholar 

  16. Aguayo A, O'Brien S, Keating M, Manshouri T, Gidel C, Barlogie B, Beran M, Koller C, Kantarjian H, Albitar M . Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia Blood 2000 96: 768–770

    CAS  PubMed  Google Scholar 

  17. Aguayo A, Estey E, Kantarjian H, Manshouri T, Gidel C, Keating M, Giles F, Estrov Z, Barlogie B, Albitar M . Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia Blood 1999 94: 3717–3721

    CAS  PubMed  Google Scholar 

  18. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM . Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth J Cell Biol 1992 119: 629–641

    Article  CAS  PubMed  Google Scholar 

  19. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM . Scatter factor induces blood vessel formation in vivo Proc Natl Acad Sci USA 1993 90: 1937–1941

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Morimoto A, Tada K, Nakayama Y, Kohno K, Naito S, Ono M, Kuwano M . Cooperative roles of hepatocyte growth factor and plasminogen activator in tubular morphogenesis by human microvascular endothelial cells Jpn J Cancer Res 1994 85: 53–62

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Jiang W, Hiscox S, Matsumoto K, Nakamura T . Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer Crit Rev Oncol Hematol 1999 29: 209–248

    Article  CAS  PubMed  Google Scholar 

  22. Roletto F, Galvani AP, Cristiani C, Valsasina B, Landonio A, Bertolero F . Basic fibroblast growth factor stimulates hepatocyte growth factor/scatter factor secretion by human mesenchymal cells J Cell Physiol 1996 166: 105–111

    Article  CAS  PubMed  Google Scholar 

  23. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, Isner JM . Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis Circulation 1998 97: 381–390

    Article  CAS  PubMed  Google Scholar 

  24. To CT, Tsao MS . The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers Oncol Rep 1998 5: 1013–1024

    CAS  PubMed  Google Scholar 

  25. Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P, Laterra J . Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression J Natl Cancer Inst 1999 91: 1548–1556

    Article  CAS  PubMed  Google Scholar 

  26. Date K, Matsumoto K, Kuba K, Shimura H, Tanaka M, Nakamura T . Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor Oncogene 1998 17: 3045–3054

    Article  CAS  PubMed  Google Scholar 

  27. Seidel C, Borset M, Turesson I, Abildgaard N, Sundan A, Waage A . Elevated serum concentrations of hepatocyte growth factor in patients with multiple myeloma. The Nordic Myeloma Study Group Blood 1998 91: 806–812

    CAS  PubMed  Google Scholar 

  28. Borset M, Hjorth-Hansen H, Seidel C, Sundan A, Waage A . Hepatocyte growth factor and its receptor c-met in multiple myeloma Blood 1996 88: 3998–4004

    CAS  PubMed  Google Scholar 

  29. Borset M, Seidel C, Hjorth-Hansen H, Waage A, Sundan A . The role of hepatocyte growth factor and its receptor c-Met in multiple myeloma and other blood malignancies Leuk Lymphoma 1999 32: 249–256

    Article  CAS  PubMed  Google Scholar 

  30. Estey E, Thall P, Beran M, Kantarjian H, Pierce S, Keating M . Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia (AML)) on outcome of AML-type chemotherapy Blood 1997 90: 2969–2977

    CAS  PubMed  Google Scholar 

  31. Pons E, Uphoff CC, Drexler HG . Expression of hepatocyte growth factor and its receptor c-met in human leukemia-lymphoma cell lines Leuk Res 1998 22: 797–804

    Article  CAS  PubMed  Google Scholar 

  32. Nakamura S, Gohda E, Matsunaga T, Yamamoto I, Minowada J . Production of hepatocyte growth factor by human haematopoietic cell lines Cytokine 1994 6: 285–294

    Article  CAS  PubMed  Google Scholar 

  33. Nakamura S, Gohda E, Matsuo Y, Yamamoto I, Minowada J . Significant amount of hepatocyte growth factor detected in blood and bone marrow plasma of leukaemia patients Br J Haematol 1994 87: 640–642

    Article  CAS  PubMed  Google Scholar 

  34. Hino M, Inaba M, Goto H, Nishizawa Y, Tatsumi N, Nishino T, Morii H . Hepatocyte growth factor levels in bone marrow plasma of patients with leukaemia and its gene expression in leukaemic blast cells Br J Cancer 1996 73: 119–123

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Hjorth-Hansen H, Seidel C, Lamvik J, Borset M, Sundan A, Waage A . Elevated serum concentrations of hepatocyte growth factor in acute myelocytic leukaemia Eur J Haematol 1999 62: 129–134

    Article  CAS  PubMed  Google Scholar 

  36. Banks RE, Forbes MA, Kinsey SE, Stanley A, Ingham E, Walters C, Selby PJ . Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology Br J Cancer 1998 77: 956–964

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Russell WE, McGowan JA, Bucher NL . Partial characterization of a hepatocyte growth factor from rat platelets J Cell Physiol 1984 119: 183–192

    Article  CAS  PubMed  Google Scholar 

  38. Strain AJ, McGowan JA, Bucher NL . Stimulation of DNA synthesis in primary cultures of adult rat hepatocytes by rat platelet-associated substance(s) In Vitro 1982 18: 108–116

    Article  CAS  PubMed  Google Scholar 

  39. Sakon M, Kita Y, Takeda Y, Higaki N, Ohzato H, Umeshita K, Hasuike Y, Gotoh M, Monden M . Measurement of hepatocyte growth factor in serum and plasma Int J Clin Lab Res 1999 29: 110–113

    Article  CAS  PubMed  Google Scholar 

  40. Weimar IS, Voermans C, Bourhis JH, Miranda N, van den Berk PC, Nakamura T, de Gast GC, Gerritsen WR . Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells Leukemia 1998 12: 1195–1203

    Article  CAS  PubMed  Google Scholar 

  41. Beilmann M, Odenthal M, Jung W, Vande Woude GF, Dienes HP, Schirmacher P . Neo-expression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes Blood 1997 90: 4450–4458

    CAS  PubMed  Google Scholar 

  42. Fuhrmann-Benzakein E, Ma MN, Rubbia-Brandt L, Mentha G, Ruefenacht D, Sappino AP, Pepper MS . Elevated levels of angiogenic cytokines in the plasma of cancer patients Int J Cancer 2000 85: 40–45

    Article  CAS  PubMed  Google Scholar 

  43. Anderlini A, Luna M, Kantarjian HM, O'Brien S, Pierce S, Keating MJ, Estey EH . Causes of initial remission induction failure in patients with acute myeloid leukemia and myelodysplastic syndrome Leukemia 1996 10: 600–608

    CAS  PubMed  Google Scholar 

  44. Singhal S, Mehta J, Desikan R, Ayers D, Roberson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B . Antitumor activity of thalidomide in refractory multiple myeloma New Engl J Med 1999 341: 1565–1571

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

SV is supported by grant T32-CA09666 from the National Institute of Health, USA.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Verstovsek, S., Kantarjian, H., Estey, E. et al. Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome. Leukemia 15, 1165–1170 (2001). https://doi.org/10.1038/sj.leu.2402182

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402182

Keywords

This article is cited by

Search

Quick links